COVID-19: How Orbis International is managing operations

Article

Danny Haddad, MD, chief of program at Orbis International, shares an update on how the company's operations have shifted during the coronavirus pandemic, as well as the record-breaking impact on one of its telehealth platforms.
 


See more coronavirus coverage here

 

Recent Videos
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A person holds an Ozempic injector pen. Image credit: ©alones – stock.adobe.com

European Medicines Agency will assess semaglutide for link to NAION

Hattie Hayes
December 20th 2024
Article

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

An ophthalmologist uses a laser device in a lab, looking at the viewer. Image credit: ©Vadim – stock.adobe.com

A history of the femtosecond laser in the United States and Europe

Prof. H. Burkhard Dick
December 19th 2024
Article

The timeline demonstrates international innovation and collaboration

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A person in a business suit holds a lit-up lightbulb. Image credit: ©kamiphotos – stock.adobe.com

EssilorLuxottica announces agreement for acquisition of Espansione Group

Sydney M Crago
December 17th 2024
Article

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

An image of a woman with irritated eyes. Image credit: ©Best – stock.adobe.com

A neurologist shares his warning about recurrent optic neuritis attacks and NMOSD

Hattie Hayes
December 17th 2024
Article

Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)

© 2024 MJH Life Sciences

All rights reserved.